ISPUB.com / IJGO/6/1/7333
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Gynecology and Obstetrics
  • Volume 6
  • Number 1

Original Article

Recurrent Failure Of Mirena Intrauterine System (IUS) Within Two Years Of Insertion In The Same Woman With The Same Device

S Acharya, N Samtaney

Keywords

contraception, ectopic pregnancy, failure rate, iud, mirena ius, miscarriage

Citation

S Acharya, N Samtaney. Recurrent Failure Of Mirena Intrauterine System (IUS) Within Two Years Of Insertion In The Same Woman With The Same Device. The Internet Journal of Gynecology and Obstetrics. 2005 Volume 6 Number 1.

Abstract

Mirena (levonorgestrel-releasing) intrauterine system (IUS) is a very reliable method of contraception with the failure rate comparable to sterilization. We present a case of recurrent failure of the Mirena IUS in-situ in the same woman with tw incidences of positive β-hCGs within two years of insertion of the same coil device, the first being suspected complete early miscarriage followed one year later by a confirmed ectopic pregnancy. Although LNG-IUS is one of the most effective methods of contraception, the risks of failure should always be kept in mind and the women be appropriately counseled before its use.

 

Case Report

The levonorgestrel-releasing intrauterine system ( Mirena IUS) has been licensed as a contraceptive in the UK since May 1995 1. A 31 year old G4P2 lady presented with complaints of sudden onset severe right iliac fossa pain for 24 hours and bleeding per vagina off and on since previous 2 weeks. Her LMP was 6 weeks previously. Urinary pregnancy test was positive. She was haemodynamically stable. Per abdominal examination revealed mild tenderness in the right iliac fossa but no associated guarding or rigidity. Speculum examination showed Mirena IUS threads in place but no evidence of active bleeding. Bimanual examination was unremarkable. Pelvic ultrasound showed a normal sized empty uterus with Mirena IUS in place. There was an adnexal mass on the right side separate from the ovary but no free fluid in the pouch of Douglas. Serum β-hCG was 674 IU/L. Diagnostic laparoscopy confirmed right sided tubal pregnancy and right salpingectomy was performed. The Mirena IUS was removed at the same time. She was discharged home the following day with a follow-up appointment to discuss various options for contraception.

She mentioned that 8 weeks following her normal delivery, 2 years previously, she had the Mirena IUS inserted without any problems. She always had regular periods following the insertion of the coil lasting 4-5 days. She gave a history of an episode of heavy bleeding per vagina 1 year since the insertion of the coil following 1 month's amenorrhoea. At that time she also had positive urinary pregnancy test and was seen in the early pregnancy assessment unit in our hospital. On examination, the threads of the coil were visible through the external os and transvaginal ultrasound confirmed empty uterus with the coil in place. She was followed up with serial β-hCGs every 48 hours, which were 312, 250 and 218 IU/L respectively. One week following this she had a further β-hCG which was 99 IU/L and she was asymptomatic. It was thought to be a case of resolving ectopic pregnancy or a complete miscarriage. The Mirena IUS was confirmed to be in place and it was within 1 year of insertion so it was not changed at that time.

Discussion

Data from randomized trials reported no ectopic pregnancies in a total of 34,944 woman-months and an annual pregnancy rate averaged 0.2 women per 100 years of LNG-IUS use 2,3. The National Health Service Health Technology Assessment Programme report also mentioned of the risk of ectopic pregnancies being similar for the LNG-IUS and modern IUDs (>250 mm2 copper) and in absolute terms it is very low indeed 4. In Finland, a large retrospective study showed that 17,360 users of the LNG IUS had a 5-year cumulative pregnancy rate per 100 users was 0.5 and the 5-year Pearl Index rate was 0.11 5.

Our case is reported because of its rarity, since extensive Medline literature search did not reveal any case of failure of Mirena IUS twice in the same woman within a space of 2 years with the same coil in place. Although LNG-IUS is one of the most effective methods of contraception, the chances of failure should always be kept in mind and the women be appropriately counseled before its use.

References

1. Faculty of Family Planning and Reproductive Health Care (FFPRHC). FFPRHC Guidance (April 2004). The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reproductive health. J Fam Plann Reprod Health Care 2004; 30(1): 99-109.
2. Sivin I, Stern J, Coutinho E, et al. Prolonged intrauterine contraception: a seven- year randomized study of the levonorgestrel 20 mcg/day (LNG 20) and the copper T380Ag IUDs. Contraception 1991; 44: 473-480.
3. Sivin I, Stern J. Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380 Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR). Fertil Steril 1994; 61: 70-77.
4. French RS, Cowan FM, Mansour DJA, et al. Implantable contraceptives (subdermal implants and hormonally impregnated intrauterine systems) versus other forms of reversible contraceptives: two systematic reviews to assess relative effectiveness, acceptability, tolerability and cost-effectiveness (Review). Health Technol Assess 2000; i-vi, 1-107.
5. Backman T, Rauramo I, Huhtala S, Koskenvuo M. Pregnancy during the use of levonorgestrel intrauterine system. Am J Obstet Gynecol. 2004;190(1):50-54.

Author Information

Santanu Acharya, MD, MRCOG
pecialist Registrar, Department of Obstetrics and Gynecology, Airedale General Hospital

Naren Samtaney, MD, FRCOG
Consultant Obstetrician and Gynecologist, Department of Obstetrics and Gynecology, Airedale General Hospital

Download PDF

Your free access to ISPUB is funded by the following advertisements:

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy